Literature DB >> 18336675

Oxidative stress in alcoholic liver disease: role of NADPH oxidase complex.

Samuele De Minicis1, David A Brenner.   

Abstract

Alcohol is a well-known risk factor for liver damage and is one of the major causes of liver disease worldwide. Chronic intake of alcohol, over a certain limit, inevitably leads to hepatic steatosis. If the injury persists, steatosis with concomitant tumor necrosis factor-alpha and other cytokines, progresses to steatohepatitis, fibrosis and finally cirrhosis. Among the multiple factors involved in the process of alcohol-induced liver injury, a crucial role is played by oxidative stress. Several mechanisms during ethanol metabolism result in reactive oxygen species (ROS) production. Although the main site of ethanol metabolism is hepatocytes, other mechanisms are involved in alcohol-induced liver injury. Specifically, in the ROS production activity, an important role is played by the NADPH oxidase complex. NADPH oxidase is expressed in hepatocytes, hepatic stellate cells and Kupffer cells in the liver. Studying NADPH oxidase gives new insights into alcohol-induced liver damage and provides new direction for future therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18336675     DOI: 10.1111/j.1440-1746.2007.05277.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  39 in total

Review 1.  Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?

Authors:  Wonhyo Seo; Won-Il Jeong
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 2.  Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.

Authors:  Paul D Berk
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

3.  ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice.

Authors:  Kai Y Mak; Ruth Chin; Sharon C Cunningham; Miriam R Habib; Joseph Torresi; Alexandra F Sharland; Ian E Alexander; Peter W Angus; Chandana B Herath
Journal:  Mol Ther       Date:  2015-05-25       Impact factor: 11.454

4.  Exposure of precision-cut rat liver slices to ethanol accelerates fibrogenesis.

Authors:  Courtney S Schaffert; Michael J Duryee; Robert G Bennett; Amy L DeVeney; Dean J Tuma; Peter Olinga; Karen C Easterling; Geoffrey M Thiele; Lynell W Klassen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-01       Impact factor: 4.052

5.  N-acetylcysteine inhibits the up-regulation of mitochondrial biogenesis genes in livers from rats fed ethanol chronically.

Authors:  Andres A Caro; Matthew Bell; Shannon Ejiofor; Grant Zurcher; Dennis R Petersen; Martin J J Ronis
Journal:  Alcohol Clin Exp Res       Date:  2014-12       Impact factor: 3.455

Review 6.  Alcoholic liver disease: mechanisms of injury and targeted treatment.

Authors:  Alexandre Louvet; Philippe Mathurin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-17       Impact factor: 46.802

7.  Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines.

Authors:  Zheng Shen; Joanne M Ajmo; Christopher Q Rogers; Xiaomei Liang; Lisa Le; Michel M Murr; Yanhua Peng; Min You
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-19       Impact factor: 4.052

8.  Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress.

Authors:  Jianguo Lin; Shizhong Zheng; Anping Chen
Journal:  Lab Invest       Date:  2009-10-19       Impact factor: 5.662

9.  Role of free radicals in liver diseases.

Authors:  Pablo Muriel
Journal:  Hepatol Int       Date:  2009-11-26       Impact factor: 6.047

10.  Perilipin 5 restores the formation of lipid droplets in activated hepatic stellate cells and inhibits their activation.

Authors:  Jianguo Lin; Anping Chen
Journal:  Lab Invest       Date:  2016-05-02       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.